Turkey

Turkey

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3 2003 Survey/reported Ozsoy MF et al, 2003
2.5 2009 Survey/reported Akcama FZ et al, 2009
2.63 (2.08 - 3.28) 2015 Modelled WHO
2.6 (1.90 - 3.50) 2016 Modelled Razavi-Shearer et al, 2018
4 (3.99 - 4.02) 2013 Modelled Schweitzer et al, 2015
2.43 (2.31 - 2.56) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.74 (2.61 - 2.88) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.81 (2.66 - 2.97) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.71 - 2.99) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.88 (2.74 - 3.04) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.93 (2.79 - 3.08) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3 (2.86 - 3.16) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.08 (2.93 - 3.24) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.15 (3 - 3.33) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.21 (3.04 - 3.40) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.27 (3.10 - 3.45) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.35 (3.19 - 3.53) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.44 (3.27 - 3.62) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3.52 (3.35 - 3.71) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3.59 (3.41 - 3.79) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (3.48 - 3.86) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.75 (3.56 - 3.95) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.85 (3.66 - 4.07) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.96 (3.74 - 4.19) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.04 (3.80 - 4.30) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.13 (3.89 - 4.39) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.24 (3.99 - 4.49) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.35 (4.09 - 4.60) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.46 (4.18 - 4.73) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.54 (4.23 - 4.83) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.61 (4.32 - 4.89) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.67 (4.39 - 4.95) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.73 (4.46 - 5.01) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.79 (4.51 - 5.07) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.84 (4.54 - 5.14) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.61 (2.49 - 2.75) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.32 (0.22 - 0.48) 2015 Modelled WHO
0.17 (0.14 - 0.20) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.21 (0.17 - 0.25) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.23 (0.19 - 0.27) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.24 (0.20 - 0.29) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.25 (0.21 - 0.29) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.26 (0.22 - 0.31) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.28 (0.23 - 0.33) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.25 - 0.35) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.31 (0.26 - 0.37) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.34 (0.28 - 0.40) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.37 (0.31 - 0.43) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.34 - 0.48) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.48 (0.40 - 0.56) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.47 - 0.66) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.55 - 0.77) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.64 - 0.90) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.74 - 1.04) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.04 (0.88 - 1.22) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.22 (1.03 - 1.44) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.42 (1.21 - 1.69) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.66 (1.39 - 1.97) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.04 (1.72 - 2.40) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (2.18 - 3.02) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.15 (2.66 - 3.68) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.63 (3.03 - 4.24) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.89 (3.23 - 4.56) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.99 (3.32 - 4.67) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.06 (3.39 - 4.79) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.12 (3.44 - 4.89) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.14 (3.47 - 4.94) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.14 (3.46 - 4.93) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.09 - 0.13) 2020 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
3.86 2015 Survey/reported EMCDDA; General Directorate of Health Service
4.21 2014 Survey/reported EMCDDA; General Directorate of Health Service
4.52 2013 Survey/reported EMCDDA; General Directorate of Health Service
8.6 2012 Survey/reported EMCDDA; General Directorate of Health Service
7.5 2011 Survey/reported EMCDDA; General Directorate of Health Service
3.56 2010 Survey/reported EMCDDA; General Directorate of Health Service
5.24 2009 Survey/reported EMCDDA; General Directorate of Health Service
8 2008 Survey/reported EMCDDA; General Directorate of Health Service
19.28 2007 Survey/reported EMCDDA; General Directorate of Health Service
17.93 2006 Survey/reported EMCDDA; General Directorate of Health Service
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
2.2 2017 Survey/reported EMCDDA
Technical notes

Number of persons living with chronic HBV

National
Download
Value Year Type Source
2,091,000 (1,536,000 - 2,786,000) 2016 Modelled Razavi-Shearer et al, 2018
1,976,310 (1,881,680 - 2,082,750) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2,042,400 (1,943,170 - 2,149,030) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2,131,330 (2,029,040 - 2,239,600) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2,177,830 (2,064,600 - 2,297,360) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2,187,020 (2,080,580 - 2,295,700) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2,193,220 (2,086,350 - 2,308,060) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2,204,830 (2,098,910 - 2,317,980) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2,224,200 (2,117,420 - 2,338,450) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2,247,870 (2,138,930 - 2,366,390) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2,274,760 (2,159,210 - 2,398,640) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2,296,240 (2,175,840 - 2,428,470) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2,323,930 (2,204,910 - 2,451,040) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2,366,600 (2,251,670 - 2,492,680) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2,412,750 (2,300,740 - 2,542,160) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2,454,680 (2,336,280 - 2,591,980) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2,484,750 (2,363,810 - 2,626,450) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2,514,880 (2,394,020 - 2,649,160) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2,556,400 (2,428,540 - 2,694,410) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2,601,120 (2,465,920 - 2,742,500) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2,643,170 (2,500,820 - 2,797,430) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,674,970 (2,520,490 - 2,845,860) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,704,570 (2,547,740 - 2,868,520) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,741,540 (2,583,920 - 2,902,240) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,777,930 (2,611,420 - 2,939,060) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,805,800 (2,631,780 - 2,977,190) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,816,860 (2,634,590 - 2,995,110) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,815,040 (2,641,960 - 2,988,570) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,809,580 (2,645,200 - 2,974,860) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2,799,700 (2,639,210 - 2,968,560) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,784,680 (2,624,990 - 2,949,760) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2,763,560 (2,604,450 - 2,935,890) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.34 (3.25 - 5.68) 2019 Modelled IHME, GBD 2019 (accessed 2020)
6.39 (4.96 - 7.86) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6.5 (5.09 - 7.90) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6.65 (5.30 - 8) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6.74 (5.40 - 8.08) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6.57 (5.19 - 7.92) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6.75 (5.43 - 8.03) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6.67 (5.44 - 7.91) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6.66 (5.51 - 7.93) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6.56 (5.40 - 7.76) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6.38 (5.33 - 7.50) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6.04 (5.09 - 7.10) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6 (5.05 - 7.11) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.07 (5.14 - 7.21) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5.8 (4.80 - 7.05) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5.3 (4.29 - 6.49) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5.61 (4.59 - 6.83) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5.45 (4.45 - 6.66) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5.07 (4.10 - 6.20) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4.84 (3.96 - 5.84) 2008 Modelled IHME, GBD 2019 (accessed 2022)
4.66 (3.87 - 5.56) 2009 Modelled IHME, GBD 2019 (accessed 2022)
4.55 (3.76 - 5.40) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4.55 (3.80 - 5.39) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4.51 (3.77 - 5.39) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.53 (3.77 - 5.41) 2014 Modelled IHME, GBD 2019 (accessed 2022)
4.51 (3.76 - 5.34) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4.52 (3.72 - 5.47) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4.36 (3.51 - 5.40) 2016 Modelled IHME, GBD 2019 (accessed 2022)
4.24 (3.31 - 5.40) 2017 Modelled IHME, GBD 2019 (accessed 2022)
4.26 (3.26 - 5.53) 2018 Modelled IHME, GBD 2019 (accessed 2022)
4.34 (3.25 - 5.68) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
4,200 2016 Modelled WHO
3,819 (2,966 - 4,696) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3,957 (3,101 - 4,811) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4,193 (3,342 - 5,038) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4,073 (3,215 - 4,912) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4,311 (3,453 - 5,171) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4,382 (3,525 - 5,215) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4,395 (3,588 - 5,210) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4,452 (3,678 - 5,296) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4,437 (3,652 - 5,254) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4,181 (3,527 - 4,919) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4,371 (3,648 - 5,134) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4,292 (3,632 - 5,097) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4,198 (3,535 - 4,974) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4,140 (3,425 - 5,029) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4,035 (3,301 - 4,912) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3,869 (3,135 - 4,740) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3,726 (3,011 - 4,560) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3,950 (3,228 - 4,832) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3,581 (2,930 - 4,316) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3,464 (2,875 - 4,131) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3,404 (2,813 - 4,037) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3,427 (2,864 - 4,060) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3,490 (2,913 - 4,164) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3,434 (2,862 - 4,072) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3,557 (2,955 - 4,247) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3,494 (2,812 - 4,329) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3,583 (2,953 - 4,337) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3,417 (2,670 - 4,353) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3,454 (2,642 - 4,483) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3,530 (2,645 - 4,618) 2019 Modelled IHME, GBD 2019 (accessed 2022)
3,530 (2,645 - 4,618) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
17 (13 - 22) 1990 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 23) 1991 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 24) 1993 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 23) 1992 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 24) 1994 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 24) 1995 Modelled IHME, GBD 2019 (accessed 2022)
20 (16 - 25) 1996 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 26) 1997 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 25) 1998 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 26) 2000 Modelled IHME, GBD 2019 (accessed 2022)
20 (16 - 24) 1999 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 27) 2001 Modelled IHME, GBD 2019 (accessed 2022)
23 (19 - 28) 2002 Modelled IHME, GBD 2019 (accessed 2022)
24 (19 - 30) 2003 Modelled IHME, GBD 2019 (accessed 2022)
25 (20 - 31) 2004 Modelled IHME, GBD 2019 (accessed 2022)
24 (19 - 30) 2007 Modelled IHME, GBD 2019 (accessed 2022)
25 (20 - 31) 2005 Modelled IHME, GBD 2019 (accessed 2022)
25 (20 - 31) 2006 Modelled IHME, GBD 2019 (accessed 2022)
23 (19 - 28) 2008 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 27) 2009 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 26) 2010 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 26) 2011 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 26) 2012 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 26) 2013 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 27) 2015 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 27) 2014 Modelled IHME, GBD 2019 (accessed 2022)
22 (18 - 27) 2016 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 28) 2017 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 28) 2018 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2019 Modelled IHME, GBD 2019 (accessed 2022)
42 (34 - 51) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
99 2019 Survey/reported WHO/UNICEF
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
97 2011 Survey/reported WHO/UNICEF
97 2010 Survey/reported WHO/UNICEF
96 2009 Survey/reported WHO/UNICEF
96 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
94 2005 Survey/reported WHO/UNICEF
88 2004 Survey/reported WHO/UNICEF
78 2003 Survey/reported WHO/UNICEF
99 2020 Survey/reported WHO/UNICEF
99 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2019 Survey/reported WHO/UNICEF
98 2020 Survey/reported WHO/UNICEF
96 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2003
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.6 (0.30 - 1) 2015 Modelled Blach et al, 2017
1.04 (0.86 - 1.29) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.06) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.66 - 0.95) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.69 - 0.95) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.71 - 0.96) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.71 - 0.95) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.71 - 0.94) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.71 - 0.92) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.70 - 0.91) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.90) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.69 - 0.89) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.67 - 0.88) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.66 - 0.86) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.65 - 0.84) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.64 - 0.83) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.63 - 0.83) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.63 - 0.83) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.62 - 0.83) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.61 - 0.83) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.61 - 0.84) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.62 - 0.86) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.63 - 0.88) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.65 - 0.92) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.67 - 0.96) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.68 - 1) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.70 - 1.04) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.73 - 1.09) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.76 - 1.15) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.80 - 1.21) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.83 - 1.28) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.82 - 1.23) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
45.77 2017 Survey/reported EMCDDA; General Directorate of Health Service
39.78 2015 Survey/reported EMCDDA; General Directorate of Health Service
42.8 2014 Survey/reported EMCDDA; General Directorate of Health Service
45.07 2013 Survey/reported EMCDDA; General Directorate of Health Service
50.1 2012 Survey/reported EMCDDA; General Directorate of Health Service
48.61 2011 Survey/reported EMCDDA; General Directorate of Health Service
32.88 2010 Survey/reported EMCDDA; General Directorate of Health Service
28.91 2009 Survey/reported EMCDDA; General Directorate of Health Service
23.48 2008 Survey/reported EMCDDA; General Directorate of Health Service
43.33 2007 Survey/reported EMCDDA; General Directorate of Health Service
55.16 2006 Survey/reported EMCDDA; General Directorate of Health Service
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.29 (0.16 - 0.45) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1 2009 Survey/reported Zeynep F et al, 2008.
0.3 2003 Survey/reported Ozsoy MF et al, 2003
1 (0.60 - 2.10) 2014 Survey/reported Gower et al, 2014
0.95 2019 Modelled Jin et al. 2017
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
45.8 2017 Survey/reported EMCDDA
Technical notes

Number of persons living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
492,000 (271,000 - 763,000) 2015 Modelled Blach et al, 2017
589,399 (479,308 - 728,557) 1990 Modelled IHME, GBD 2019 (accessed 2022)
570,988 (466,584 - 708,112) 1991 Modelled IHME, GBD 2019 (accessed 2022)
552,723 (452,166 - 682,311) 1992 Modelled IHME, GBD 2019 (accessed 2022)
536,066 (439,619 - 657,444) 1993 Modelled IHME, GBD 2019 (accessed 2022)
522,518 (429,363 - 635,170) 1994 Modelled IHME, GBD 2019 (accessed 2022)
513,788 (423,712 - 620,933) 1995 Modelled IHME, GBD 2019 (accessed 2022)
506,548 (422,410 - 603,500) 1996 Modelled IHME, GBD 2019 (accessed 2022)
496,780 (416,523 - 588,086) 1997 Modelled IHME, GBD 2019 (accessed 2022)
486,736 (410,257 - 572,549) 1998 Modelled IHME, GBD 2019 (accessed 2022)
479,192 (404,831 - 561,280) 1999 Modelled IHME, GBD 2019 (accessed 2022)
477,420 (403,624 - 558,709) 2000 Modelled IHME, GBD 2019 (accessed 2022)
480,560 (411,281 - 557,392) 2001 Modelled IHME, GBD 2019 (accessed 2022)
484,996 (419,688 - 561,200) 2002 Modelled IHME, GBD 2019 (accessed 2022)
490,874 (427,102 - 562,421) 2003 Modelled IHME, GBD 2019 (accessed 2022)
498,090 (433,631 - 566,658) 2004 Modelled IHME, GBD 2019 (accessed 2022)
506,754 (442,378 - 578,241) 2005 Modelled IHME, GBD 2019 (accessed 2022)
517,624 (452,385 - 590,501) 2006 Modelled IHME, GBD 2019 (accessed 2022)
530,090 (463,309 - 604,100) 2007 Modelled IHME, GBD 2019 (accessed 2022)
543,011 (475,183 - 618,129) 2008 Modelled IHME, GBD 2019 (accessed 2022)
555,140 (486,888 - 630,325) 2009 Modelled IHME, GBD 2019 (accessed 2022)
565,808 (495,345 - 643,438) 2010 Modelled IHME, GBD 2019 (accessed 2022)
577,090 (504,809 - 655,527) 2011 Modelled IHME, GBD 2019 (accessed 2022)
590,549 (515,487 - 672,236) 2012 Modelled IHME, GBD 2019 (accessed 2022)
605,660 (527,157 - 694,618) 2013 Modelled IHME, GBD 2019 (accessed 2022)
620,296 (536,093 - 713,465) 2014 Modelled IHME, GBD 2019 (accessed 2022)
632,484 (543,249 - 731,541) 2015 Modelled IHME, GBD 2019 (accessed 2022)
625,383 (529,330 - 727,919) 2016 Modelled IHME, GBD 2019 (accessed 2022)
623,031 (512,389 - 736,221) 2017 Modelled IHME, GBD 2019 (accessed 2022)
686,331 (562,900 - 826,735) 2018 Modelled IHME, GBD 2019 (accessed 2022)
815,142 (670,233 - 1,006,820) 2019 Modelled IHME, GBD 2019 (accessed 2022)
808,638 (664,031 - 999,651) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
63,500 (35,000 - 98,500) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
3.22 (2.35 - 4.29) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.83 (1.89 - 3.74) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (1.88 - 3.65) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.68 (1.89 - 3.49) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.71 (1.89 - 3.57) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.67 (1.89 - 3.44) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.65 (1.93 - 3.39) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.62 (1.92 - 3.34) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.62 (1.94 - 3.29) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.64 (1.97 - 3.33) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.44 (1.87 - 2.99) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (1.93 - 3.18) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (1.93 - 3.06) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.45 (1.91 - 3) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.38 (1.81 - 2.99) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.32 (1.76 - 2.97) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.32 (1.75 - 2.95) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.57 (1.94 - 3.26) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.42 (1.83 - 3.09) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.28 (1.73 - 2.91) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.69 (2.10 - 3.38) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (2.20 - 3.46) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.8 (2.24 - 3.52) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.8 (2.23 - 3.49) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.82 (2.23 - 3.48) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.20 - 3.53) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.84 (2.24 - 3.49) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.96 (2.25 - 3.76) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.1 (2.33 - 4.04) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.16 (2.33 - 4.10) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.22 (2.35 - 4.29) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
2,492 2016 Modelled WHO
2,624 (1,910 - 3,491) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2,624 (1,910 - 3,491) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2,558 (1,891 - 3,326) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2,501 (1,883 - 3,262) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2,371 (1,804 - 3,012) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2,258 (1,742 - 2,802) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2,225 (1,756 - 2,739) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2,181 (1,722 - 2,691) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2,131 (1,700 - 2,656) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2,114 (1,689 - 2,654) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2,071 (1,644 - 2,587) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2,003 (1,564 - 2,516) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,898 (1,438 - 2,413) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,777 (1,348 - 2,272) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,691 (1,277 - 2,151) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,651 (1,253 - 2,112) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,668 (1,267 - 2,139) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,701 (1,294 - 2,130) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,757 (1,364 - 2,162) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,712 (1,334 - 2,096) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,688 (1,293 - 2,070) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,750 (1,322 - 2,178) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,770 (1,314 - 2,228) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,763 (1,313 - 2,222) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,730 (1,265 - 2,202) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,725 (1,254 - 2,201) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,709 (1,209 - 2,201) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,686 (1,192 - 2,201) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,680 (1,172 - 2,215) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,688 (1,145 - 2,224) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,689 (1,127 - 2,238) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
8 (6 - 12) 1990 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1991 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1992 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1993 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 1995 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 1998 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2000 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2001 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2002 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2004 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2003 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2005 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 16) 2006 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 2007 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 17) 2008 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 2009 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 17) 2010 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 17) 2011 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 17) 2012 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 18) 2014 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 18) 2013 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2016 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 2015 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2017 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 20) 2018 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 20) 2019 Modelled IHME, GBD 2019 (accessed 2022)
28 (21 - 35) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2003
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
2.61 (%)
2019
(2.49 - 2.75(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
1.04 (%)
2019
(0.86 - 1.29(%))
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

HBV (HBsAg+)
2.5 (%)
2009
Akcama FZ et al, 2009
HCV (anti-HCV)
1 (%)
2014
(0.6 - 2.1(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
3,530
2019
(2,645 - 4,618)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
2,624
2019
(1,910 - 3,491)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.11 (%)
2020, latest modelled
(0.09 - 0.13(%))
WHO

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
99 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

Action plan

View all

News

Action plans

Resources

Programs

Partners